The Centers for Medicare & Medicaid Services has posted a FAQ on the Coronavirus Aid, Relief, and Economic Security Act requirement that providers of COVID-19 diagnostic tests make public the cash price for the tests on their website during the public health emergency.

The FAQ also notes that under the CARES Act and Families First Coronavirus Response Act, group health plans generally must reimburse providers of COVID-19 diagnostic tests at the negotiated rate or cash price, and cover certain COVID-19 diagnostic testing without cost sharing, prior authorization or other medical management requirements during the public health emergency.

Related News Articles

Headline
The Federal Emergency Management Agency is reminding stakeholders that funding is available under FEMA’s Public Assistance program, including for…
Headline
The Centers for Medicare & Medicaid Services today released an interim final rule requiring long-term care facilities in the Medicare and Medicaid…
Headline
The Department of the Treasury yesterday released an interim final rule implementing $350 billion in American Rescue Plan Act funding to help state, local…
Headline
The Food and Drug Administration today announced the expansion of its emergency use authorization for Pfizer’s COVID-19 vaccine to include adolescents ages 12…
Headline
Learn what design and engineering changes are under consideration by hospital and health system leaders like Bradley Pollitt, vice president of facilities at…
Headline
Illinois health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence in…